{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:53:34Z","timestamp":1789480414450,"version":"build-2803163510"},"reference-count":254,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Key R&amp;D Program of China","award":["2023YFF1104400"],"award-info":[{"award-number":["2023YFF1104400"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Objective: L-carnitine (LC), a vital nutritional supplement, plays a crucial role in myocardial health and exhibits significant cardioprotective effects. LC, being the principal constituent of clinical-grade supplements, finds extensive application in the recovery and treatment of diverse cardiovascular and cerebrovascular disorders. However, controversies persist regarding the utilization of LC in nervous system diseases, with varying effects observed across numerous mental and neurological disorders. This article primarily aims to gather and analyze database information to comprehensively summarize the therapeutic potential of LC in patients suffering from nervous system diseases while providing valuable references for further research. Methods: A comprehensive search was conducted in PubMed, Web Of Science, Embase, Ovid Medline, Cochrane Library and Clinicaltrials.gov databases. The literature pertaining to the impact of LC supplementation on neurological or psychiatric disorders in patients was reviewed up until November 2023. No language or temporal restrictions were imposed on the search. Results: A total of 1479 articles were retrieved, and after the removal of duplicates through both automated and manual exclusion processes, 962 articles remained. Subsequently, a meticulous re-screening led to the identification of 60 relevant articles. Among these, there were 12 publications focusing on hepatic encephalopathy (HE), while neurodegenerative diseases (NDs) and peripheral nervous system diseases (PNSDs) were represented by 9 and 6 articles, respectively. Additionally, stroke was addressed in five publications, whereas Raynaud\u2019s syndrome (RS) and cognitive disorder (CD) each had three dedicated studies. Furthermore, migraine, depression, and amyotrophic lateral sclerosis (ALS) each accounted for two publications. Lastly, one article was found for other symptoms under investigation. Conclusion: In summary, LC has demonstrated favorable therapeutic effects in the management of HE, Alzheimer\u2019s disease (AD), carpal tunnel syndrome (CTS), CD, migraine, neurofibromatosis (NF), PNSDs, RS, and stroke. However, its efficacy appears to be relatively limited in conditions such as ALS, ataxia, attention deficit hyperactivity disorder (ADHD), depression, chronic fatigue syndrome (CFS), Down syndrome (DS), and sciatica.<\/jats:p>","DOI":"10.3390\/nu16081232","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T03:57:07Z","timestamp":1713758227000},"page":"1232","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4345-1088","authenticated-orcid":false,"given":"Wenbo","family":"Wang","sequence":"first","affiliation":[{"name":"Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Pan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Public Health, School of Medicine, Xizang Minzu University, Xianyang 712082, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China"},{"name":"Department of Public Health, School of Medicine, Xizang Minzu University, Xianyang 712082, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7503-7655","authenticated-orcid":false,"given":"Shaokang","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, and Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China"},{"name":"Department of Public Health, School of Medicine, Xizang Minzu University, Xianyang 712082, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alhasaniah, A.H. (2023). l-carnitine: Nutrition, pathology, and health benefits. Saudi J. Biol. Sci., 30.","DOI":"10.1016\/j.sjbs.2022.103555"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Almannai, M., Alfadhel, M., and El-Hattab, A.W. (2019). Carnitine Inborn Errors of Metabolism. Molecules, 24.","DOI":"10.3390\/molecules24183251"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: Role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"ref_4","first-page":"73","article-title":"Translating the basic knowledge of mitochondrial functions to metabolic therapy: Role of L-carnitine","volume":"161","author":"Marcovina","year":"2013","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s11064-017-2288-7","article-title":"L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain","volume":"42","author":"Ferreira","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_6","unstructured":"Group OCEBM Levels of Evidence Working (2011). The Oxford 2011 Levels of Evidence, Oxford Centre for Evidence-Based Medicine."},{"key":"ref_7","first-page":"644","article-title":"OCEBM levels of evidence system","volume":"68","author":"Durieux","year":"2013","journal-title":"Rev. Med. Liege"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.24272\/j.issn.2095-8137.2022.289","article-title":"Animal models of Alzheimer\u2019s disease: Applications, evaluation, and perspectives","volume":"43","author":"Chen","year":"2022","journal-title":"Zool. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_10","first-page":"54","article-title":"Observations on an ethnic classification of idiots. 1866","volume":"33","author":"Down","year":"1995","journal-title":"Ment. Retard."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/gps.930061205","article-title":"Acetyl-L-Carnitine in dementia","volume":"6","author":"Livingston","year":"1991","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1753-4887.1992.tb01306.x","article-title":"Acetyl-Carnitine and Alzheimer\u2019s Disease","volume":"50","author":"Bowman","year":"1992","journal-title":"Nutr. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-4580(95)80001-8","article-title":"Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer\u2019s disease","volume":"16","author":"Pettegrew","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.47.3.705","article-title":"A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer\u2019s disease","volume":"47","author":"Thal","year":"1996","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1041610298005304","article-title":"Acetyl L-carnitine slows decline in younger patients with Alzheimer\u2019s disease: A reanalysis of a double-blind, placebo-controlled study using the trilinear approach","volume":"10","author":"Brooks","year":"1998","journal-title":"Int. Psychogeriatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.55.6.805","article-title":"A 1-year controlled trial of acetyl-l-carnitine in early-onset AD","volume":"55","author":"Thal","year":"2000","journal-title":"Neurology"},{"key":"ref_17","first-page":"16","article-title":"Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer\u2019s disease and vascular dementia","volume":"111","author":"Gavrilova","year":"2011","journal-title":"Zhurnal Nevrol. Psikhiatrii Im. S.S. Korsakova"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12779\/dnd.2018.17.1.1","article-title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease","volume":"17","author":"Yang","year":"2018","journal-title":"Dement. Neurocogn. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ridd.2004.07.009","article-title":"The effect of acetyl-L-carnitine administration on persons with Down syndrome","volume":"27","author":"Pueschel","year":"2006","journal-title":"Res. Dev. Disabil."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"Hardiman","year":"2017","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/21678421.2013.764568","article-title":"Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS","volume":"14","author":"Beghi","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1007\/s00415-023-11844-6","article-title":"Retrospective observational study on the use of acetyl-L-carnitine in ALS","volume":"270","author":"Sassi","year":"2023","journal-title":"J. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00002826-200003000-00010","article-title":"Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia","volume":"23","author":"Sorbi","year":"2000","journal-title":"Clin. Neuropharmacol."},{"key":"ref_24","first-page":"1208","article-title":"Ataxia","volume":"22","author":"Ashizawa","year":"2016","journal-title":"Continuum (Minneapolis, Minn.)"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(15)00238-X","article-title":"Attention deficit hyperactivity disorder","volume":"387","author":"Thapar","year":"2016","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/cap.2007.018","article-title":"Acetyl-L-carnitine (ALC) in attention-deficit\/hyperactivity disorder: A multi-site, placebo-controlled pilot trial","volume":"17","author":"Arnold","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1474-4422(16)30231-9","article-title":"Carpal tunnel syndrome: Clinical features, diagnosis, and management","volume":"15","author":"Padua","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40263-017-0476-2","article-title":"L-Acetyl-carnitine in Patients with Carpal Tunnel Syndrome: Effects on Nerve Protection, Hand Function and Pain","volume":"31","author":"Cruccu","year":"2017","journal-title":"CNS Drugs"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pharmthera.2019.05.013","article-title":"Cognitive dysfunction in major depression: From assessment to novel therapies","volume":"202","author":"Neill","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00213-004-1773-2","article-title":"The influence on cognition of the interactions between lecithin, carnitine and carbohydrate","volume":"175","author":"Benton","year":"2004","journal-title":"Psychopharmacology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.archger.2007.03.012","article-title":"Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue","volume":"46","author":"Malaguarnera","year":"2008","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.2174\/1381612828666220830092815","article-title":"Acetyl-L-carnitine Slows the Progression from Prefrailty to Frailty in Older Subjects: A Randomized Interventional Clinical Trial","volume":"28","author":"Malaguarnera","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-clinpsy-032210-104535","article-title":"The origins and current status of behavioral activation treatments for depression","volume":"7","author":"Dimidjian","year":"2011","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/bmb\/lds004","article-title":"The neurobiology of depression","volume":"101","author":"Palazidou","year":"2012","journal-title":"Br. Med. Bull."},{"key":"ref_35","first-page":"169","article-title":"L-acetylcarnitine treatment of mental decline in the elderly","volume":"20","author":"Salvioli","year":"1994","journal-title":"Drugs Exp. Clin. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.euroneuro.2012.11.013","article-title":"L-Acetylcarnitine in dysthymic disorder in elderly patients: A double-blind, multicenter, controlled randomized study vs. fluoxetine","volume":"23","author":"Bersani","year":"2013","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-108-3-387","article-title":"Chronic fatigue syndrome: A working case definition","volume":"108","author":"Holmes","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0140-6736(88)92107-1","article-title":"What is myalgic encephalomyelitis?","volume":"331","author":"Lloyd","year":"1988","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.5694\/j.1326-5377.1990.tb126191.x","article-title":"Prevalence of chronic fatigue syndrome in an Australian population","volume":"153","author":"Lloyd","year":"1990","journal-title":"Med. J. Aust."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/014107689108400224","article-title":"A report--chronic fatigue syndrome: Guidelines for research","volume":"84","author":"Sharpe","year":"1991","journal-title":"J. R. Soc. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.psy.0000116249.60477.e9","article-title":"Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome","volume":"66","author":"Vermeulen","year":"2004","journal-title":"Psychosom. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jnen\/nly061","article-title":"Histological Features of Cerebellar Neuropathology in Patients With Alcoholic and Nonalcoholic Steatohepatitis","volume":"77","author":"Balzano","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(00)05270-3","article-title":"Evidence for a cerebral effect of the hepatitis C virus","volume":"358","author":"Forton","year":"2001","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41424-018-0038-z","article-title":"Magnetic resonance imaging evidence of hippocampal structural changes in patients with primary biliary cholangitis","volume":"9","author":"Mosher","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/apt.13797","article-title":"Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging","volume":"44","author":"Grover","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00044011-200222001-00002","article-title":"Efficacy of L-carnitine in reducing hyperammonaemia and improving neuropsychological test performance in patients with hepatic cirrhosis: Results of a randomised trial","volume":"22","author":"Cecere","year":"2002","journal-title":"Clin. Drug Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000073347","article-title":"L-Carnitine in the treatment of mild or moderate hepatic encephalopathy","volume":"21","author":"Malaguarnera","year":"2003","journal-title":"Dig. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3748\/wjg.v11.i45.7197","article-title":"Effects of L-carnitine in patients with hepatic encephalopathy","volume":"11","author":"Malaguarnera","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1007\/s10620-006-9187-0","article-title":"Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: Randomized double-blind, placebo-controlled trial","volume":"51","author":"Malaguarnera","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1440-1681.2006.04327.x","article-title":"Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy","volume":"33","author":"Siciliano","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1007\/s10620-008-0238-6","article-title":"Acetyl-L-carnitine treatment in minimal hepatic encephalopathy","volume":"53","author":"Malaguarnera","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3109\/00365521.2011.565067","article-title":"Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy","volume":"46","author":"Malaguarnera","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3945\/ajcn.110.007393","article-title":"Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: A randomized, double-blind, placebo-controlled study","volume":"93","author":"Malaguarnera","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11011-011-9260-z","article-title":"Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: A randomized and controlled clinical trial","volume":"26","author":"Malaguarnera","year":"2011","journal-title":"Metab. Brain Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/hepr.12565","article-title":"Serum level of taurine would be associated with the amelioration of minimal hepatic encephalopathy in cirrhotic patients","volume":"46","author":"Saito","year":"2016","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3904\/kjim.2021.338","article-title":"Effect of L-carnitine on quality of life in covert hepatic encephalopathy: A randomized, double-blind, placebo-controlled study","volume":"37","author":"Yoon","year":"2022","journal-title":"Korean J. Intern. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/head.12189","article-title":"The International Classification of Headache Disorders, 3rd Edition (ICHD III)\u2014Changes and Challenges","volume":"53","author":"Levin","year":"2013","journal-title":"Headache J. Head Face Pain"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/01.WNL.0000052998.58526.A9","article-title":"Premonitory symptoms in migraine: An electronic diary study","volume":"60","author":"Giffin","year":"2003","journal-title":"Neurology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s10194-016-0689-7","article-title":"Characterising the premonitory stage of migraine in children: A clinic-based study of 100 patients in a specialist headache service","volume":"17","author":"Karsan","year":"2016","journal-title":"J. Headache Pain"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(18)30478-1","article-title":"Migraine","volume":"391","author":"Dodick","year":"2018","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12011-012-9487-5","article-title":"The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis","volume":"150","author":"Mahdavi","year":"2012","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/0333102414566817","article-title":"Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study","volume":"35","author":"Hagen","year":"2015","journal-title":"Cephalalgia Int. J. Headache"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: A complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2003.11.005","article-title":"Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: Results of a pilot, randomised, double-blind, crossover trial","volume":"218","author":"Tomassini","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.wco.0000044763.39452.aa","article-title":"Neurofibroma and schwannoma","volume":"15","author":"Ferner","year":"2002","journal-title":"Curr. Opin. Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/ajmg.a.62392","article-title":"L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial","volume":"185","author":"Vasiljevski","year":"2021","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-802973-2.00015-X","article-title":"Chapter 15\u2014Peripheral neuropathies","volume":"Volume 138","author":"Aminoff","year":"2016","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00126839-200203040-00001","article-title":"Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study","volume":"3","author":"Minardi","year":"2002","journal-title":"Drugs R&D"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.28.1.89","article-title":"Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: An analysis of two randomized placebo-controlled trials","volume":"28","author":"Sima","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_74","first-page":"169","article-title":"Effect of L-carnitine on diabetic neuropathy and ventricular dispersion in patients with diabetes mellitus","volume":"40","author":"Ulvi","year":"2010","journal-title":"Turk. J. Med. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.3892\/etm.2016.3871","article-title":"A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy","volume":"12","author":"Sun","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/jdi.12493","article-title":"Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial","volume":"7","author":"Li","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: From clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev-cellbio-092910-154121","article-title":"The role of MeCP2 in the brain","volume":"27","author":"Guy","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archneurol.2011.149","article-title":"Rett syndrome: Exploring the autism link","volume":"68","author":"Percy","year":"2011","journal-title":"Arch. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fpsyt.2012.00034","article-title":"Rett syndrome: Genes, synapses, circuits, and therapeutics","volume":"3","author":"Banerjee","year":"2012","journal-title":"Front. Psychiatry"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tins.2015.12.008","article-title":"Rett Syndrome: Crossing the Threshold to Clinical Translation","volume":"39","author":"Katz","year":"2016","journal-title":"Trends Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneurol.2016.186","article-title":"Clinical and biological progress over 50 years in Rett syndrome","volume":"13","author":"Leonard","year":"2017","journal-title":"Nat. Reviews Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/brain\/awy323","article-title":"Towards a better diagnosis and treatment of Rett syndrome: A model synaptic disorder","volume":"142","author":"Banerjee","year":"2019","journal-title":"Brain J. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/088307389901400306","article-title":"Rett syndrome: Randomized controlled trial of L-carnitine","volume":"14","author":"Ellaway","year":"1999","journal-title":"J. Child Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0387-7604(01)00346-1","article-title":"Medium-term open label trial of L-carnitine in Rett syndrome","volume":"23","author":"Ellaway","year":"2001","journal-title":"Brain Dev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00246-005-0784-z","article-title":"Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: Prevention of sudden death?","volume":"26","author":"Guideri","year":"2005","journal-title":"Pediatr. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.sc.3102080","article-title":"A brief history of sciatica","volume":"45","author":"Pearce","year":"2007","journal-title":"Spinal Cord"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJM198802043180506","article-title":"Back pain and sciatica","volume":"318","author":"Frymoyer","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM193408022110506","article-title":"Rupture of the Intervertebral Disc with Involvement of the Spinal Canal","volume":"211","author":"MIXTER","year":"1934","journal-title":"N. Engl. J. Med."},{"key":"ref_90","first-page":"1253","article-title":"Relationship between severity of lumbar disc disease and disability scores in sciatica patients","volume":"50","author":"Porchet","year":"2002","journal-title":"Neurosurgery"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMra1410151","article-title":"Sciatica","volume":"372","author":"Ropper","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2165\/00044011-200828080-00004","article-title":"Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: A randomized, double-blind, comparative study","volume":"28","author":"Memeo","year":"2008","journal-title":"Clin. Drug Investig."},{"key":"ref_93","first-page":"113","article-title":"Cerebrovascular disease in the community: Results of a WHO collaborative study","volume":"58","author":"Aho","year":"1980","journal-title":"Bull. World Health Organ."},{"key":"ref_94","first-page":"427","article-title":"Chapter 36\u2014Stroke","volume":"Volume 110","author":"Barnes","year":"2013","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s11055-014-0007-2","article-title":"Use of L-Carnitine in Patients with Chronic Cerebral Ischemia","volume":"44","author":"Fedotova","year":"2014","journal-title":"Neurosci. Behav. Physiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.17116\/jnevro201711712265-69","article-title":"A study of the efficacy and safety of L-carnitine in patients with ischemic stroke in the early rehabilitation period","volume":"117","author":"Chichanovskaya","year":"2017","journal-title":"Zhurnal Nevrol. Psikhiatrii Im. S.S. Korsakova"},{"key":"ref_97","first-page":"111","article-title":"Evaluation of Neuroprtective Effects of L-Carnitine and Fat Emulsion in the CVA Patients: A Prospective, Randomized, Double Blind, Clinical Trial","volume":"19","author":"Kazemian","year":"2020","journal-title":"Iran. J. Pharm. Res. IJPR"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2493053","DOI":"10.1155\/2022\/2493053","article-title":"Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial","volume":"2022","author":"Mazdeh","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"428010","DOI":"10.1155\/2012\/428010","article-title":"Mechanism of Oxidative Stress in Neurodegeneration","volume":"2012","author":"Gandhi","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"609421","DOI":"10.1155\/2012\/609421","article-title":"Preclinical and clinical evidence of antioxidant effects of antidepressant agents: Implications for the pathophysiology of major depressive disorder","volume":"2012","author":"Behr","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.56.12.1449","article-title":"The role of oxidative stress in Alzheimer disease","volume":"56","author":"Markesbery","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pnpbp.2012.06.018","article-title":"N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats","volume":"39","author":"Smaga","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"Oxidative stress in Alzheimer\u2019s disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci. Bull."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","article-title":"Role of oxidative stress in depression","volume":"25","author":"Bhatt","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","article-title":"Oxidative & nitrosative stress in depression: Why so much stress?","volume":"45","author":"Moylan","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.fertnstert.2021.09.013","article-title":"Associations between depression, oxidative stress, and semen quality among 1,000 healthy men screened as potential sperm donors","volume":"117","author":"Ye","year":"2022","journal-title":"Fertil. Steril."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archneur.1995.00540300031009","article-title":"Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis","volume":"52","author":"Louwerse","year":"1995","journal-title":"Arch. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41594-020-00537-7","article-title":"TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS","volume":"28","author":"Zuo","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.celrep.2019.09.066","article-title":"Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia","volume":"29","author":"Tam","year":"2019","journal-title":"Cell Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","article-title":"Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy","volume":"2","author":"Areti","year":"2014","journal-title":"Redox Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1007\/s12035-023-03342-7","article-title":"Oxidative Stress in Diabetic Peripheral Neuropathy: Pathway and Mechanism-Based Treatment","volume":"60","author":"Lin","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1089\/ars.2021.0152","article-title":"Oxidative Stress and Mitochondrial Dysfunction Associated with Peripheral Neuropathy in Type 1 Diabetes","volume":"37","author":"Eftekharpour","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.mam.2004.06.003","article-title":"Role of carnitine esters in brain neuropathology","volume":"25","author":"Virmani","year":"2004","journal-title":"Mol. Asp. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0304-3940(02)00667-5","article-title":"Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons","volume":"329","author":"Bigini","year":"2002","journal-title":"Neurosci. Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1046\/j.1460-9568.2002.02299.x","article-title":"Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system","volume":"16","author":"Bertamini","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12989-016-0115-y","article-title":"An acetyl-L-carnitine switch on mitochondrial dysfunction and rescue in the metabolomics study on aluminum oxide nanoparticles","volume":"13","author":"Li","year":"2016","journal-title":"Part. Fibre Toxicol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2016.06.046","article-title":"Acetyl-l-carnitine restores synaptic transmission and enhances the inducibility of stable LTP after oxygen-glucose deprivation","volume":"332","author":"Kocsis","year":"2016","journal-title":"Neuroscience"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neulet.2017.07.059","article-title":"Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor","volume":"658","author":"Kazak","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/cpr.12080","article-title":"Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: Role of apoptosis-related genes and pro-inflammatory cytokines","volume":"47","author":"Altun","year":"2014","journal-title":"Cell Prolif."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.18632\/aging.202187","article-title":"Carnitine promotes recovery from oxidative stress and extends lifespan in C. elegans","volume":"13","author":"Liu","year":"2020","journal-title":"Aging"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jmhi.2013.02.003","article-title":"Synergistic effect of probiotics, butyrate and l-Carnitine in treatment of IBD","volume":"7","author":"Moeinian","year":"2013","journal-title":"J. Med. Hypotheses Ideas"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12944-016-0277-5","article-title":"Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease","volume":"15","author":"Lee","year":"2016","journal-title":"Lipids Health Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/13813455.2020.1797102","article-title":"L-Carnitine supplementation reduces biomarkers of inflammatory and oxidative stress in patients with coronary artery disease: A randomised controlled trial","volume":"129","author":"Nachvak","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_129","first-page":"74","article-title":"Analyzing Mitochondrial Dysfunction, Oxidative Stress, and Apoptosis: Potential Role of L-carnitine","volume":"13","author":"Modanloo","year":"2019","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"646171","DOI":"10.1155\/2015\/646171","article-title":"Potential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions","volume":"2015","author":"Montesano","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/00071660120109980","article-title":"Dietary L-carnitine increases plasma insulin-like growth factor-I concentration in chicks fed a diet with adequate dietary protein level","volume":"43","author":"Kita","year":"2002","journal-title":"Br. Poult. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Keller, J., Ringseis, R., and Eder, K. (2014). Supplemental carnitine affects the microRNA expression profile in skeletal muscle of obese Zucker rats. BMC Genom., 15.","DOI":"10.1186\/1471-2164-15-512"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-10-28","article-title":"Supplementation of carnitine leads to an activation of the IGF-1\/PI3K\/Akt signalling pathway and down regulates the E3 ligase MuRF1 in skeletal muscle of rats","volume":"10","author":"Keller","year":"2013","journal-title":"Nutr. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.lfs.2005.05.103","article-title":"Antioxidant and antiradical activities of L-carnitine","volume":"78","year":"2006","journal-title":"Life Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S1461145702003097","article-title":"Cytokines as a stressor: Implications for depressive illness","volume":"5","author":"Anisman","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00001648-200301000-00025","article-title":"Inflammatory proteins and depression in the elderly","volume":"14","author":"Tiemeier","year":"2003","journal-title":"Epidemiology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0006-3223(02)01811-5","article-title":"Inflammatory markers and depressed mood in older persons: Results from the Health, Aging and Body Composition study","volume":"54","author":"Penninx","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/01.CIR.0000164203.54111.AE","article-title":"Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"111","author":"Empana","year":"2005","journal-title":"Circulation"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Berk, M., Williams, L.J., Jacka, F.N., O\u2019Neil, A., Pasco, J.A., Moylan, S., Allen, N.B., Stuart, A.L., Hayley, A.C., and Byrne, M.L. (2013). So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-200"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S2215-0366(18)30255-4","article-title":"Rheumatoid arthritis and depression: An inflammatory perspective","volume":"6","author":"Nerurkar","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"eabj0264","DOI":"10.1126\/scitranslmed.abj0264","article-title":"Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS","volume":"14","author":"Hop","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Twarowski, B., and Herbet, M. (2023). Inflammatory Processes in Alzheimer\u2019s Disease-Pathomechanism, Diagnosis and Treatment: A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076518"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"101317","DOI":"10.1016\/j.arr.2021.101317","article-title":"Inflammatory pathways in Alzheimer\u2019s disease mediated by gut microbiota","volume":"68","author":"Qian","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_145","first-page":"1027","article-title":"Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy","volume":"44","author":"Jain","year":"2012","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/hep.24228","article-title":"Hepatic encephalopathy: A central neuroinflammatory disorder?","volume":"53","author":"Butterworth","year":"2011","journal-title":"Hepatology"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/187152707780619326","article-title":"Gliogenesis and glial pathology in depression","volume":"6","author":"Rajkowska","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2003.11.004","article-title":"Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and\/or interferon-alpha cancer therapy","volume":"18","author":"Capuron","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.etap.2017.12.005","article-title":"Acetyl-l-carnitine attenuates arsenic-induced liver injury by abrogation of mitochondrial dysfunction, inflammation, and apoptosis in rats","volume":"58","author":"Sepand","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1167\/iovs.14-16247","article-title":"Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial Cells","volume":"56","author":"Hua","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cbi.2018.02.034","article-title":"L-carnitine mitigates UVA-induced skin tissue injury in rats through downregulation of oxidative stress, p38\/c-Fos signaling, and the proinflammatory cytokines","volume":"285","author":"Salama","year":"2018","journal-title":"Chem. -Biol. Interact."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"323","DOI":"10.18388\/abp.2012_2116","article-title":"NF-\u03baB signaling pathway and free radical impact","volume":"59","author":"Siomek","year":"2012","journal-title":"Acta Biochim. Pol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s40200-020-00627-9","article-title":"The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Fathizadeh","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_155","first-page":"3211","article-title":"Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients","volume":"21","author":"Duranay","year":"2006","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. Eur. Ren. Assoc."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/07315724.2015.1068139","article-title":"Effects of l-Carnitine Supplementation on Serum Inflammatory Factors and Matrix Metalloproteinase Enzymes in Females with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study","volume":"35","author":"Mahdavi","year":"2016","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/cbf.1807","article-title":"Effect of L-carnitine on the synthesis of nitric oxide in RAW 264\u00b77 murine macrophage cell line","volume":"29","author":"Koc","year":"2011","journal-title":"Cell Biochem. Funct."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2478\/jomb-2014-0030","article-title":"Effect of L-carnitine Supplementation on Circulating C-reactive Protein Levels: A Systematic Review and Meta-Analysis","volume":"34","author":"Sahebkar","year":"2015","journal-title":"J. Med. Biochem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e016863","DOI":"10.1136\/bmjopen-2017-016863","article-title":"The effect of nut consumption on markers of inflammation and endothelial function: A systematic review and meta-analysis of randomised controlled trials","volume":"7","author":"Neale","year":"2017","journal-title":"BMJ Open"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2018.03.010","article-title":"VDAC1, mitochondrial dysfunction, and Alzheimer\u2019s disease","volume":"131","author":"Gupta","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-022-02613-9","article-title":"Mitochondrial dysfunction in microglia: A novel perspective for pathogenesis of Alzheimer\u2019s disease","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.drudis.2021.04.025","article-title":"Mitochondrial dysfunction: A potential target for Alzheimer\u2019s disease intervention and treatment","volume":"26","author":"Ke","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.mito.2004.07.021","article-title":"Mitochondrial damage and dysfunction in traumatic brain injury","volume":"4","author":"Lifshitz","year":"2004","journal-title":"Mitochondrion"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"740939","DOI":"10.3389\/fphys.2021.740939","article-title":"Traumatic Brain Injury: Mechanisms of Glial Response","volume":"12","author":"Mira","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/9780470725207.ch13","article-title":"Mitochondria and neurodegeneration","volume":"287","author":"Beal","year":"2007","journal-title":"Novartis Found. Symp."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: Etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mds.26966","article-title":"Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson\u2019s disease","volume":"32","author":"Giannoccaro","year":"2017","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bph.15684","article-title":"Targeting \u03b1-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson\u2019s disease","volume":"179","author":"Haque","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","article-title":"Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis","volume":"20","author":"Witte","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12974-024-03016-8","article-title":"Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis","volume":"21","author":"Wang","year":"2024","journal-title":"J. Neuroinflamm."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41582-021-00581-x","article-title":"Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis","volume":"18","author":"Yong","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","article-title":"Mitochondrial dysfunction in ALS","volume":"97","author":"Cozzolino","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Zhao, J., Wang, X., Huo, Z., Chen, Y., Liu, J., Zhao, Z., Meng, F., Su, Q., Bao, W., and Zhang, L. (2022). The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis. Cells, 11.","DOI":"10.3390\/cells11132049"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications","volume":"17","author":"Chia","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Song, Y., Cao, H., Zuo, C., Gu, Z., Huang, Y., Miao, J., Fu, Y., Guo, Y., Jiang, Y., and Wang, F. (2023). Mitochondrial dysfunction: A fatal blow in depression. Biomed. Pharmacother., 167.","DOI":"10.1016\/j.biopha.2023.115652"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/1570159X14666160229114755","article-title":"Mitochondrial Dysfunction in Depression","volume":"14","author":"Bansal","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41380-022-01806-1","article-title":"Molecular pathways of major depressive disorder converge on the synapse","volume":"28","author":"Fries","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.1425","article-title":"Mitochondria and degenerative disorders","volume":"106","author":"Orth","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/07853890801923753","article-title":"Mitochondrial involvement in psychiatric disorders","volume":"40","author":"Shao","year":"2008","journal-title":"Ann. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.psy.47.1.1","article-title":"Review of the literature on major mental disorders in adult patients with mitochondrial diseases","volume":"47","author":"Fattal","year":"2006","journal-title":"Psychosomatics"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1092852900015303","article-title":"Psychiatric comorbidity in 36 adults with mitochondrial cytopathies","volume":"12","author":"Fattal","year":"2007","journal-title":"CNS Spectr."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0006-3223(96)00062-5","article-title":"31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique--preliminary findings","volume":"41","author":"Volz","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0006-3223(97)00425-3","article-title":"In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy","volume":"44","author":"Kegeles","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0893-133X(99)00111-6","article-title":"Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics","volume":"22","author":"Prince","year":"2000","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/oxfordjournals.schbul.a033331","article-title":"Positron emission tomography studies of abnormal glucose metabolism in schizophrenia","volume":"24","author":"Buchsbaum","year":"1998","journal-title":"Schizophr. Bull."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1399-5618.2000.020302.x","article-title":"Neuroimaging in bipolar disorder","volume":"2","author":"Strakowski","year":"2000","journal-title":"Bipolar Disord."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.biopsych.2003.12.012","article-title":"Mitochondrial complex I subunits expression is altered in schizophrenia: A postmortem study","volume":"55","author":"Karry","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"ref_191","first-page":"1315","article-title":"Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction","volume":"31","author":"Jun","year":"2011","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s003950050167","article-title":"Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions","volume":"95","author":"Calvani","year":"2000","journal-title":"Basic Res. Cardiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/0024-3205(82)90677-4","article-title":"The distribution and role of carnitine in the mammalian brain","volume":"31","author":"Shug","year":"1982","journal-title":"Life Sci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1684\/epd.2013.0575","article-title":"Valproic acid-induced hyperammonaemic coma and unrecognised portosystemic shunt","volume":"15","author":"Nzwalo","year":"2013","journal-title":"Epileptic Disord."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome: Implications for a dopamine hypothesis of bipolar disorder","volume":"116","author":"Berk","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/schbul\/sbq031","article-title":"Dopaminergic dysfunction in schizophrenia: Salience attribution revisited","volume":"36","author":"Heinz","year":"2010","journal-title":"Schizophr. Bull."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","article-title":"Neural mechanisms of addiction: The role of reward-related learning and memory","volume":"29","author":"Hyman","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12035-012-8278-5","article-title":"Role of dopamine receptors in ADHD: A systematic meta-analysis","volume":"45","author":"Wu","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review","volume":"55","author":"Deepmala","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1300.066","article-title":"Anatomical substrates for glutamate-dopamine interactions: Evidence for specificity of connections and extrasynaptic actions","volume":"1003","author":"Sesack","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","article-title":"The role of dopamine oxidation in mitochondrial dysfunction: Implications for Parkinson\u2019s disease","volume":"41","author":"Hastings","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0306-4522(00)00293-1","article-title":"Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine","volume":"101","author":"Rabinovic","year":"2000","journal-title":"Neuroscience"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/joim.12049","article-title":"The role of dopamine receptors in the neurotoxicity of methamphetamine","volume":"273","author":"Granado","year":"2013","journal-title":"J. Intern. Med."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tins.2006.01.002","article-title":"Dopamine in neurotoxicity and neuroprotection: What do D2 receptors have to do with it?","volume":"29","author":"Bozzi","year":"2006","journal-title":"Trends Neurosci."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1515\/revneuro-2016-0068","article-title":"Neurotransmission systems in Parkinson\u2019s disease","volume":"28","author":"Rahmani","year":"2017","journal-title":"Rev. Neurosci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12035-016-0293-5","article-title":"Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats","volume":"55","author":"Singh","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jnr.1220","article-title":"Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats","volume":"66","author":"Ando","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"ref_209","first-page":"Cd001190","article-title":"Donepezil for dementia due to Alzheimer\u2019s disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/brain\/awac096","article-title":"Reimagining cholinergic therapy for Alzheimer\u2019s disease","volume":"145","author":"Giacobini","year":"2022","journal-title":"Brain J. Neurol."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Stanciu, G.D., Luca, A., Rusu, R.N., Bild, V., Beschea Chiriac, S.I., Solcan, C., Bild, W., and Ababei, D.C. (2019). Alzheimer\u2019s Disease Pharmacotherapy in Relation to Cholinergic System Involvement. Biomolecules, 10.","DOI":"10.3390\/biom10010040"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"33s","DOI":"10.2967\/jnumed.121.263198","article-title":"PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders","volume":"63","author":"Tiepolt","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11910-021-01140-z","article-title":"Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views","volume":"21","author":"Kanel","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/npjparkd.2016.1","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease","volume":"2","author":"Barrantes","year":"2016","journal-title":"NPJ Park. Dis."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.10.022","article-title":"Effects of augmenting cholinergic neurotransmission on balance in Parkinson\u2019s disease","volume":"69","author":"Mancini","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00702-006-0579-2","article-title":"The significance of the cholinergic system in the brain during aging and in Alzheimer\u2019s disease","volume":"113","author":"Schliebs","year":"2006","journal-title":"J. Neural Transm."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-001-0496-8","article-title":"Amitriptyline and clomipramine activate Gi-protein signaling pathway in the induction of analgesia","volume":"365","author":"Ghelardini","year":"2002","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(89)90826-4","article-title":"Acetyl-L-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats","volume":"107","author":"Imperato","year":"1989","journal-title":"Neurosci. Lett."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","article-title":"Glutamate as a neurotransmitter in the healthy brain","volume":"121","author":"Zhou","year":"2014","journal-title":"J. Neural Transm."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-0173(90)90011-C","article-title":"Physiological and pathophysiological roles of excitatory amino acids during central nervous system development","volume":"15","author":"McDonald","year":"1990","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Baj, A., Moro, E., Bistoletti, M., Orlandi, V., Crema, F., and Giaroni, C. (2019). Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061482"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1096\/fasebj.1.6.2890549","article-title":"Glutamate and related acidic excitatory neurotransmitters: From basic science to clinical application","volume":"1","author":"Robinson","year":"1987","journal-title":"FASEB J."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","article-title":"Excitotoxicity, calcium and mitochondria: A triad in synaptic neurodegeneration","volume":"11","author":"Verma","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: Physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zhang, S., Fu, P., Zhang, Z., Lin, K., Ko, J.K., and Yung, K.K. (2019). Roles of Glutamate Receptors in Parkinson\u2019s Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184391"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Campanelli, F., Natale, G., Marino, G., Ghiglieri, V., and Calabresi, P. (2022). Striatal glutamatergic hyperactivity in Parkinson\u2019s disease. Neurobiol. Dis., 168.","DOI":"10.1016\/j.nbd.2022.105697"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awr028","article-title":"Glutamate NMDA receptor dysregulation in Parkinson\u2019s disease with dyskinesias","volume":"134","author":"Ahmed","year":"2011","journal-title":"Brain"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/14728222.2019.1586885","article-title":"Targeting metabotropic glutamate receptors in the treatment of epilepsy: Rationale and current status","volume":"23","author":"Celli","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1523\/JNEUROSCI.18-20-08382.1998","article-title":"Patterns of status epilepticus-induced neuronal injury during development and long-term consequences","volume":"18","author":"Sankar","year":"1998","journal-title":"J. Neurosci."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/neu.2015.4373","article-title":"Glutamate Neurotransmission in Rodent Models of Traumatic Brain Injury","volume":"34","author":"Dorsett","year":"2017","journal-title":"J. Neurotrauma"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"108609","DOI":"10.1016\/j.pharmthera.2024.108609","article-title":"Mechanistic and therapeutic relationships of traumatic brain injury and \u03b3-amino-butyric acid (GABA)","volume":"256","author":"Witkin","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Boccuni, I., Bas-Orth, C., Bruehl, C., Draguhn, A., and Fairless, R. (2023). Glutamate transporter contribution to retinal ganglion cell vulnerability in a rat model of multiple sclerosis. Neurobiol. Dis., 187.","DOI":"10.1016\/j.nbd.2023.106306"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/jnc.15884","article-title":"Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model","volume":"166","author":"Errico","year":"2023","journal-title":"J. Neurochem."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","article-title":"Glutamate-induced excitotoxicity in Parkinson\u2019s disease: The role of glial cells","volume":"144","author":"Iovino","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Andersen, J.V., Schousboe, A., and Verkhratsky, A. (2022). Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: Integration of the glutamate\/GABA-glutamine cycle. Prog. Neurobiol., 217.","DOI":"10.1016\/j.pneurobio.2022.102331"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pharmtox-021821-091747","article-title":"Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer\u2019s Disease","volume":"62","author":"Ferguson","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"108719","DOI":"10.1016\/j.neuropharm.2021.108719","article-title":"Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration","volume":"196","author":"Andersen","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1570159X16666180302115032","article-title":"Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson\u2019s Disease and Huntington\u2019s Disease: A Review","volume":"17","author":"Jamwal","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fnins.2015.00469","article-title":"Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?","volume":"9","author":"Lewerenz","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Vukolova, M.N., Yen, L.Y., Khmyz, M.I., Sobolevsky, A.I., and Yelshanskaya, M.V. (2023). Parkinson\u2019s disease, epilepsy, and amyotrophic lateral sclerosis-emerging role of AMPA and kainate subtypes of ionotropic glutamate receptors. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1252953"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/A:1021922305036","article-title":"Prevention of ammonia and glutamate neurotoxicity by carnitine: Molecular mechanisms","volume":"17","author":"Llansola","year":"2002","journal-title":"Metab. Brain Dis."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00971588","article-title":"L-carnitine increases the affinity of glutamate for quisqualate receptors and prevents glutamate neurotoxicity","volume":"19","author":"Felipo","year":"1994","journal-title":"Neurochem. Res."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1054\/bjoc.1999.0933","article-title":"Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases","volume":"82","author":"Breitkreutz","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Kao, Y.C., Ho, P.C., Tu, Y.K., Jou, I.M., and Tsai, K.J. (2020). Lipids and Alzheimer\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041505"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00232-020-00140-3","article-title":"Current Insights into Fatty Acid Transport in the Brain","volume":"253","author":"Ioannou","year":"2020","journal-title":"J. Membr. Biol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plefa.2017.04.004","article-title":"Fatty acid transporting proteins: Roles in brain development, aging, and stroke","volume":"136","author":"Zhang","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","article-title":"Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity","volume":"177","author":"Ioannou","year":"2019","journal-title":"Cell"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.devcel.2018.05.002","article-title":"Emerging Links between Lipid Droplets and Motor Neuron Diseases","volume":"45","author":"Pennetta","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1101\/gad.315564.118","article-title":"A C9orf72-CARM1 axis regulates lipid metabolism under glucose starvation-induced nutrient stress","volume":"32","author":"Liu","year":"2018","journal-title":"Genes Dev."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1083\/jcb.201902061","article-title":"Spastin tethers lipid droplets to peroxisomes and directs fatty acid trafficking through ESCRT-III","volume":"218","author":"Chang","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease","volume":"13","author":"Talloczy","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.1090439","article-title":"Yeast cells provide insight into alpha-synuclein biology and pathobiology","volume":"302","author":"Outeiro","year":"2003","journal-title":"Science"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0165-3806(83)90020-2","article-title":"Postnastal changes in the concentration of carnitine and acylcarnitines in the rat brain","volume":"284","author":"Morris","year":"1983","journal-title":"Brain Res."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.jrn.2018.08.014","article-title":"The Renal Safety of L-Carnitine, L-Arginine, and Glutamine in Athletes and Bodybuilders","volume":"29","author":"Karimzadeh","year":"2019","journal-title":"J. Ren. Nutr."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/8\/1232\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:31:45Z","timestamp":1760106705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/8\/1232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":254,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["nu16081232"],"URL":"https:\/\/doi.org\/10.3390\/nu16081232","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,20]]}}}